C14orf54 Activators encompass a diverse group of chemical compounds that, while not directly interacting with C14orf54, facilitate its functional activity within its associated signaling pathways. Forskolin, by increasing cAMP, and IBMX, through inhibiting phosphodiesterases, both raise the levels of cyclic nucleotides, leading to the activation of PKA and other cAMP/cGMP-dependent kinases; this can indirectly result in the phosphorylation of C14orf54 or its partners, enhancing its signaling capacity. Similarly, PMA stimulates PKC, potentially phosphorylating C14orf54-related proteins and amplifying its activity in PKC-dependent pathways. Ionomycin and A23187, both acting as calcium ionophores, elevate intracellular calcium levels, which may activate calcium-dependent kinases that target C14orf54 for activation. Calyculin A and Okadaic acid, as phosphatase inhibitors, prevent the dephosphorylation of proteins within the C14orf54 pathway, possibly maintaining C14orf54 in an active state.
Further supporting the activity of C14orf54, Anisomycin, through the induction of stress-activated protein kinases, could lead to the activation of C14orf54 in response to cellular stress or apoptotic signals. The cAMPand cGMP analogs, 8-Br-cAMP and 8-Br-cGMP, mimic the effects of the endogenous cyclic nucleotides, potentially activating PKA or PKG, respectively, and thus promoting the activation of C14orf54 through these kinase pathways. Thapsigargin, by inhibiting the SERCA pump, causes an increase in cytosolic calcium, which can subsequently activate calcium-dependent signaling cascades that involve C14orf54. Finally, Staurosporine, despite being a broad-spectrum kinase inhibitor, may paradoxically enhance the functional activity of C14orf54 by inhibiting kinases that normally suppress C14orf54's signaling pathways, thereby allowing for an increase in the protein's functional activity. Collectively, these activators work through distinct but interconnected biochemical mechanisms to enhance the activity of C14orf54, ensuring the protein's participation in the proper functioning of its associated cellular signaling networks.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, which increases intracellular cAMP and cGMP levels. Elevated cAMP/cGMP can enhance C14orf54 activity by stimulating signaling pathways that depend on these cyclic nucleotides. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can lead to the phosphorylation of substrates that may include C14orf54 or its associated proteins, thereby enhancing its function within its signaling pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent kinases that may phosphorylate and activate C14orf54 or its related proteins. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of proteins. This could result in enhanced activity of C14orf54 by preventing dephosphorylation of proteins in pathways where C14orf54 is involved. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is another inhibitor of protein phosphatases 1 and 2A, which may increase the phosphorylation state of proteins in the C14orf54 pathway, potentially enhancing its activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases (SAPKs/JNKs), possibly leading to the activation of C14orf54 within the context of stress response or apoptosis signaling pathways. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cAMP analog that activates cAMP-dependent pathways, potentially leading to the activation of C14orf54 through phosphorylation events mediated by PKA. | ||||||
8-Bromo-cGMP | 51116-01-9 | sc-200316 sc-200316A | 10 mg 50 mg | $104.00 $354.00 | 7 | |
8-Br-cGMP is a cGMP analog that activates cGMP-dependent pathways, potentially leading to the activation of C14orf54 through phosphorylation events mediated by PKG. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to an increase in cytosolic calcium, which may activate calcium-dependent proteins and pathways, potentially enhancing the function of C14orf54. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium concentration, potentially activating C14orf54 by promoting the activity of calcium-dependent signaling pathways. | ||||||